|
|
|
|
|
|
| Return to Savvy Consumer Information Center - Home Page |
 |
 |
References
American Cancer Society. Cancer Facts and Figures 1997.
Barry, MJ. A Nationwide Survey of Practicing Urologists: Current Management of Benign Prostatic Hyperplasia and Clinically Localized Prostate Cancer. I Urol 158:488-491, 1997.
Barry, MJ. The Natural History of Patients with Benign Prostatic Hyperplasia as Diagnosed by North American Urologists. I Urol 157:10-14, 1997.
Brawley, OW and Kramer, BS. The Epidemiology and Prevention of Prostate Cancer. Prostate Cancer pp 47-64, Wiley-Liss, 1994.
Catalona, WJ, et al. Measurement of PSA in Serum as a Screening Test for Prostate Cancer. NEJM 324:1156-1161, 1991.
Cockett, ATK, et al. Indications for Treatment of BPH. The AUA Study. Cancer 70:280-283, 1992.
Giovanucci, E, et al. Intake of Carotenoids and Retinol in Relation to Risk of Prostate Cancer. JNCI 87:1767-1776, 1995.
Grayhack, JT Benign Prostatic Hyperplasia. The Scope of the Problem. Cancer 70 (1 suppl): 275-279, 1992.
Guess, HA. Benign Prostate Enlargement: Antecedents and Natural History. Epidemiol Rev 14:131-153, 1992.
Jacobsen, SJ, et al. New Diagnostic and Treatment Guidelines for Benign Prostatic Hyperplasia. Potential Impact in the United States. Arch Int Med 155:477-481 1995.
Lee, C, et al. Etiology of Benign Prostatic Hyperplasia. Urol Clin North America 22:237-246, 1995.
Lepor, H, et al. The Effcacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia. NEJM 335:533-539, 1996.
McConnell, JD, et al. United States Public Health Service. Clinical Practice Guidelines. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Quick Reference Guide for Clinicians. AHCPR Publication No. 94-0583. February 1994.
Mettlin, CJ, et al. The National Cancer Data Base Report on Longitudinal Observations on Prostate Cancer. 77:2162-2166, 1996.
Oesterling, JE. Benign Prostatic Hyperplasia: Its Natural History, Epidemiologic Characteristics, and Surgical Therapy. Arch Family Med 1:257-266, 1992.
O'Leary, MP Epidemiology of Benign Prostatic Hyperplasia. Br, Urol 76 (supplement 1): 1-13, 1995.
Potosky, AL, et al. The Role of Increasing Detection in the Rising Incidence of Prostate Cancer. JAMA 273:548-552, 1995.
Roehrborn, CG, et al. TUNA for BPH: 12 Months of a Prospective, Multicenter US Study. Urology 51:415-421, 1998.
Spann, SJ. Prostate Cancer Screening What's a Physician To Do? Amer Family Physician 56 (6): 1997.
Treating Your Enlarged Prostate. Benign Prostate Hyperplasia Patient Guide. AHCPR Publication No. 94-0584. February 1994.
Wasson, JH. Finasteride to Prevent Morbidity From Benign Prostatic Hyperplasia. NEJM 338:612-613, 1998.
Wasson, JH, et al. A Comparison of Transurethral Surgery With Watchful Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia. NEJM 335:533-539, 1995.
Wennberg, JE, et al. Patient Outcomes Research Team Findings: Prostate Diseases.. AHCPR Publication No. 95-0086. August 1995.
|
|
| Return to Savvy Consumer Information Center - Home Page |
|
|
|
|
|
|
|
Get the Savvy Consumer Newsletter! (FREE)
|
|